Foundayo (Orforglipron) is a new oral treatment currently being studied for individuals who are overweight or living with obesity. The drug belongs to a class of medications known as GLP-1 receptor agonists. Its mechanism of action is similar to certain existing injectable treatments for weight management, but it is designed to be taken in tablet form. It is also being explored as a potential treatment for type 2 diabetes. As the drug is still in the clinical research phase, it has not yet been approved or made available in the European Union. We will provide updates as soon as there are any developments.
Slimming
Foundayo (Orforglipron)
Tablet

In short
- For overweight and weight management
- Still in the research phase
- Tablet containing orforglipron
- Not yet available or approved
What is Foundayo (Orforglipron)?
How does Foundayo (Orforglipron) work?
Side effects of Foundayo (Orforglipron)
Research on Foundayo (Orforglipron)
Status and availability of Foundayo (Orforglipron)
What treatments are currently available?
Scientific sources
Related products
View other options that may suit you.






